HealthTree

Your Feed

Filter by

See content from

BPDCN Community Gather Event image

BPDCN Community Gather Event

03:00PM - 04:00PM EDT

More info & registration

Follicular Lymphoma Community Gather: Connection & Conversation image

Follicular Lymphoma Community Gather: Connection & Conversation

01:00PM - 02:00PM EDT

More info & registration

Gather Community Event: Care-Partner Connection & Conversation - NOT RECORDED image

Gather Community Event: Care-Partner Connection & Conversation - NOT RECORDED

04:00PM - 05:00PM EDT

More info & registration

Cirtuvivint Alone & with ASTX727 for AML & MDS image

Cirtuvivint Alone & with ASTX727 for AML & MDS

03:00PM - 04:00PM EDT

More info & registration

Thumbnail for Uninsured or Underinsured With Cancer? Your Coverage Options Explained

Playlist: Dollars & Diagnosis: A Financial Podcast with Diahanna Valentine

Uninsured or Underinsured With Cancer? Your Coverage Options Explained

Video details & playlist

Study Explores Benefits of Outpatient Induction Therapy for AML

Study Explores Benefits of Outpatient Induction Therapy for AML image

Lymphoma Rash: What It Looks Like, Where It Appears, and What to Know

Lymphoma Rash: What It Looks Like, Where It Appears, and What to Know image

Does Everyone Diagnosed with Multiple Myeloma Need A Stem Cell Transplant?

Does Everyone Diagnosed with Multiple Myeloma Need A Stem Cell Transplant? image

Standard of Care, CAR-T, and Bispecific Antibodies in Multiple Myeloma: A Research Roundtable on Patient Experiences and Treatment Impact image

Standard of Care, CAR-T, and Bispecific Antibodies in Multiple Myeloma: A Research Roundtable on Patient Experiences and Treatment Impact

04:00PM - 05:00PM EDT

Watch Recording

New FDA-Approved Treatments for Triple-Negative Breast Cancer in 2026

New FDA-Approved Treatments for Triple-Negative Breast Cancer in 2026 image

Monthly Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions image

Monthly Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

06:00PM - 07:00PM EDT

Watch Recording

FDA Approves Dostarlimab (Jemperli), First Immunotherapy for Locally Advanced Rectal Cancer

FDA Approves Dostarlimab (Jemperli), First Immunotherapy for Locally Advanced Rectal Cancer image

Can Mezigdomide Help Elranatamab Work Better? Early Results From the MELT-MM Trial

Can Mezigdomide Help Elranatamab Work Better? Early Results From the MELT-MM Trial image

What Are the Different Types of Leukemia?

What Are the Different Types of Leukemia? image

Tuberculosis and Cancer: Risks, Misdiagnosis, and Prevention Steps

Tuberculosis and Cancer: Risks, Misdiagnosis, and Prevention Steps image

Is There a Connection Between Autoimmune Diseases and Cancer?

Is There a Connection Between Autoimmune Diseases and Cancer? image

Thumbnail for BCMA Bispecifics in Myeloma: Do Real-World Results Match Clinical Trials? | IMS 2026

Playlist: IMS 2026

BCMA Bispecifics in Myeloma: Do Real-World Results Match Clinical Trials? | IMS 2026

Video details & playlist

Thumbnail for Why Is Multiple Myeloma Diagnosis Delayed? 6 Journey Types to Diagnosis | IMS 2026

Playlist: IMS 2026

Why Is Multiple Myeloma Diagnosis Delayed? 6 Journey Types to Diagnosis | IMS 2026

Video details & playlist

Thumbnail for Etentamig in Heavily Pretreated Myeloma: Phase 3 CERVINO Results | IMS 2026 #myeloma

Playlist: IMS 2026

Etentamig in Heavily Pretreated Myeloma: Phase 3 CERVINO Results | IMS 2026 #myeloma

Video details & playlist

Thumbnail for Neuropathy in Smoldering Myeloma: More Common Than Expected | IMS 2026 #myeloma

Playlist: IMS 2026

Neuropathy in Smoldering Myeloma: More Common Than Expected | IMS 2026 #myeloma

Video details & playlist

Thumbnail for Cilta-Cel CAR-T for Myeloma: Which Patients Benefit From Earlier Treatment? | IMS 2026

Playlist: IMS 2026

Cilta-Cel CAR-T for Myeloma: Which Patients Benefit From Earlier Treatment? | IMS 2026

Video details & playlist

Thumbnail for KRd Lowers Progression Risk in High-Risk Smoldering Myeloma | IMS 2026

Playlist: IMS 2026

KRd Lowers Progression Risk in High-Risk Smoldering Myeloma | IMS 2026

Video details & playlist

Thumbnail for First Relapse in Myeloma: Barriers to CAR-T, Bispecifics & New Treatments | IMS 2026

Playlist: IMS 2026

First Relapse in Myeloma: Barriers to CAR-T, Bispecifics & New Treatments | IMS 2026

Video details & playlist

ASCO 2026 Vaccination Guidelines for Cancer Patients

ASCO 2026 Vaccination Guidelines for Cancer Patients image

More from HealthTree